Literature DB >> 15681724

Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling.

C S Bradshaw1, L I Pierce, S N Tabrizi, C K Fairley, S M Garland.   

Abstract

BACKGROUND: Injecting drug users (IDUs) are a marginalised population, who infrequently access health services for screening for sexually transmitted infections (STIs) and blood borne viruses (BBVs), and are at high risk of these infections.
OBJECTIVES: To use street outreach and self collection of samples for STI screening, to establish the prevalence of BBVs and STIs, and to identify risk behaviours among a group of culturally diverse street based IDUs.
METHODS: This was a cross sectional study of 314 IDUs in the central business district of Melbourne, Australia, conducted over 3 years (1999-2002). We used street outreach as the recruitment strategy with staff "on foot" in injecting and dealing locations, as well as self collected genital sampling to increase acceptance of screening for Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis by polymerase chain reaction (PCR). Individuals were screened for hepatitis A, B, and C, syphilis and HIV, and given the option of a self collected or clinician collected blood sample to increase acceptance of screening for BBVs.
RESULTS: Street outreach was highly effective and self directed STI sampling was more acceptable than practitioner directed sampling (76% versus 9% acceptance, p<0.001). There was a high prevalence of hepatitis C (74%, 95% CI 69 to 79), STIs (8% (5 to 13)), and chlamydia (6% (3 to 10)), and past exposure to hepatitis A and B was common. High rates of recent sharing of injecting equipment, unprotected sex and casual sexual partners, together with low levels of awareness of current hepatitis C infection were identified.
CONCLUSION: Street outreach and self collected genital samples facilitate screening for STIs and BBVs in IDUs and revealed a high prevalence of infections and risk behaviours.

Entities:  

Mesh:

Year:  2005        PMID: 15681724      PMCID: PMC1763716          DOI: 10.1136/sti.2004.009423

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  30 in total

1.  Homeless young people: an important risk group for sexually transmitted infections.

Authors:  D A Rosenthal; C K Fairley; S M Garland; S N Tabrizi; K Raynor; C Edwards; S Gregson; J Walsh
Journal:  Med J Aust       Date:  2000-03-06       Impact factor: 7.738

2.  HIV among injecting drug users of Indo-Chinese ethnicity in Victoria.

Authors:  Jane S Hocking; Peter G Higgs; Cathy M Keenan; Nick Crofts
Journal:  Med J Aust       Date:  2002-02-18       Impact factor: 7.738

3.  Drug treatment services for ethnic communities in Victoria, Australia: an examination of cultural and institutional barriers.

Authors:  G Reid; N Crofts; L Beyer
Journal:  Ethn Health       Date:  2001-02       Impact factor: 2.772

Review 4.  STD control in drug users and street youth.

Authors:  A van den Hoek
Journal:  Genitourin Med       Date:  1997-08

5.  Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae among at-risk women, young sex workers, and street youth attending community organizations in Quebec City, Canada.

Authors:  C Poulin; M Alary; F Bernier; D Carbonneau; M C Boily; J R Joly
Journal:  Sex Transm Dis       Date:  2001-08       Impact factor: 2.830

6.  Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Collaboration of Australian NSPs.

Authors:  M A MacDonald; A D Wodak; K A Dolan; I van Beek; P H Cunningham; J M Kaldor
Journal:  Med J Aust       Date:  2000-01-17       Impact factor: 7.738

7.  Risk behaviours of young Indo-Chinese injecting drug users in Sydney and Melbourne.

Authors:  L Maher; P Sargent; P Higgs; N Crofts; J Kelsall; T T Le
Journal:  Aust N Z J Public Health       Date:  2001       Impact factor: 2.939

8.  Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s.

Authors:  A J Freeman; A Zekry; L R Whybin; C E Harvey; I A van Beek; S L de Kantzow; W D Rawlinson; C R Boughton; P W Robertson; G Marinos; A R Lloyd
Journal:  Med J Aust       Date:  2000-06-19       Impact factor: 7.738

9.  Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers.

Authors:  R M Resnick; M T Cornelissen; D K Wright; G H Eichinger; H S Fox; J ter Schegget; M M Manos
Journal:  J Natl Cancer Inst       Date:  1990-09-19       Impact factor: 13.506

10.  Comparison of tampon and urine as self-administered methods of specimen collection in the detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women.

Authors:  S N Tabrizi; B A Paterson; C K Fairley; F J Bowden; S M Garland
Journal:  Int J STD AIDS       Date:  1998-06       Impact factor: 1.359

View more
  13 in total

1.  Investigation of a cluster of syphilis, gonorrhea, and chlamydia cases among heterosexual Micronesians living on Oahu.

Authors:  Alan R Katz; Adrianne M Cadorna; Maria Veneranda C Lee; Alan Komeya; Mandy Kiaha; Roy G Ohye
Journal:  J Community Health       Date:  2009-10

2.  From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections.

Authors:  Marcia M Hobbs; Barbara van der Pol; Patricia Totten; Charlotte A Gaydos; Anna Wald; Terri Warren; Rachel L Winer; Robert L Cook; Carolyn D Deal; M Elizabeth Rogers; Julius Schachter; King K Holmes; David H Martin
Journal:  Sex Transm Dis       Date:  2008-01       Impact factor: 2.830

3.  Demographics, sexual risk behaviours and uptake of screening for sexually transmitted infections among attendees of a weekly women-only community clinic program.

Authors:  Melanie L A Rusch; Jean A Shoveller; Susan Burgess; Karen Stancer; David M Patrick; Mark W Tyndall
Journal:  Can J Public Health       Date:  2008 Jul-Aug

4.  Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.

Authors:  Holly Hagan; Enrique R Pouget; Don C Des Jarlais; Corina Lelutiu-Weinberger
Journal:  Am J Epidemiol       Date:  2008-10-09       Impact factor: 4.897

Review 5.  A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups.

Authors:  Corina Lelutiu-Weinberger; Enrique R Pouget; Don D C Des Jarlais; Hannah L Cooper; Roberta Scheinmann; Rebecca Stern; Shiela M Strauss; Holly Hagan
Journal:  Soc Sci Med       Date:  2008-12-04       Impact factor: 4.634

6.  Does integrating viral hepatitis services into a public STD clinic attract injection drug users for care?

Authors:  Robin R Hennessy; Isaac B Weisfuse; Karen Schlanger
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

7.  Epidemiology of hepatitis C virus (HCV) infection.

Authors:  Theodore Sy; M Mazen Jamal
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

8.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16

Review 9.  The prevalence of Chlamydia trachomatis infection in Australia: a systematic review and meta-analysis.

Authors:  Dyani Lewis; Danielle C Newton; Rebecca J Guy; Hammad Ali; Marcus Y Chen; Christopher K Fairley; Jane S Hocking
Journal:  BMC Infect Dis       Date:  2012-05-14       Impact factor: 3.090

10.  What needs to change to increase chlamydia screening in general practice in Australia? The views of general practitioners.

Authors:  Jane S Hocking; Rhian M Parker; Natasha Pavlin; Christopher K Fairley; Jane M Gunn
Journal:  BMC Public Health       Date:  2008-12-30       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.